COVID vaccine made by Canada's Medicago shows promising results in Phase 2 clinical trial May 18, 2021 Canada's first homegrown vaccine for COVID-19 is showing promising antibody results in hundreds of participants in a Phase 2 trial and could be ready for a final authorization request this summer, the drugmaker says. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.